In long term data presented from the RAVEL trial, the original trial reporting a remarkable decrease in the rate of restenosis with DES, the long-term incidence of death or heart attack was not significantly different between DES and bare metal stents.
In long term data presented from the RAVEL trial, the original trial reporting a remarkable decrease in the rate of restenosis with DES, the long-term incidence of death or heart attack was not significantly different between DES and bare metal stents.
